Abstract

Pancreatic acinar cell carcinoma (PACC) is a rare malignancy accounting for 0.2%–4.3% of pancreatic tumours, typically affecting older men. Cystic variants are exceptionally uncommon and often mimic benign pancreatic lesions, posing diagnostic challenges. We report a 37-year-old woman who was incidentally found to have a large multiseptated lesion involving the pancreas, spleen, and retroperitoneal structures. Surgical exploration demonstrated multiple peritoneal and hepatic nodules. Distal pancreatectomy, splenectomy, omentectomy, and resection of hepatic lesions were performed. Histopathology confirmed poorly differentiated pancreatic acinar cell carcinoma with extensive peritoneal metastases. Postoperative recovery was uneventful. This case highlights a rare cystic presentation of PACC in an atypical demographic. Clinicians should maintain a high index of suspicion for rare pancreatic malignancies in the differential diagnosis of complex cystic abdominal lesions.

Introduction

Pancreatic acinar cell carcinoma (PACC) is an exceedingly rare pancreatic malignancy, accounting for only 0.2%–4.3% of all pancreatic carcinomas and predominantly affecting males in their sixth decade of life [1]. Despite its rarity, PACC incidence has increased by ~73% over the past decade, likely reflecting enhanced diagnostic modalities and the increased use of cross-sectional imaging [2].

The clinical presentation of PACC is often nonspecific. Many cases are detected incidentally on routine imaging, particularly in younger patients who may remain entirely asymptomatic despite harboring advanced disease [1]. Unlike the typical solid architecture that characterizes most pancreatic malignancies, PACC can rarely present as multiseptated cystic lesions, causing significant diagnostic challenges that mimic benign pancreatic neoplasms such as mucinous cystic neoplasms, serous cystadenomas, or pancreatic neuroendocrine tumours [3, 4].

Cystic PACC is extremely uncommon, with <10 cases reported in the literature [5]. Furthermore, PACC overwhelmingly affects older men, making diagnosis in young women particularly unusual [1, 5].

We present a rare case of cystic PACC in a 37-year-old woman with incidentally discovered multiseptated abdominal masses and extensive peritoneal carcinomatosis.

Case report

A 37-year-old woman was referred for further evaluation after incidental discovery of splenic and hepatic masses during an infertility workup. She was asymptomatic, denying abdominal pain, weight loss, fever, fatigue, or gastrointestinal complaints.

Her medical history included only a caesarian section 7 years earlier. She took no medications, had no relevant family history apart from diabetes mellitus, and denied smoking, alcohol, or drug use.

Imaging

Magnetic resonance imaging (MRI) of the abdomen showed a right para-capsular hepatic lesion (28 × 20 mm) with high T2 and low T1 signal and progressive nodular peripheral enhancement. A second multiseptated lesion measuring 10 × 7.8 × 7.2 cm was identified between the spleen, kidney, and pancreas. The mass had thick enhancing walls, irregular septations up to 6 mm, and mass effect on the splenic hilum and pancreatic tail, raising suspicion for malignancy.

Given interval growth and radiologic concern, surgical excision was planned.

Operative findings

A left extended subcostal incision revealed multiple suspicious nodules on the omentum and colonic mesentery. Omentectomy was performed. A large left-sided mass was found abutting the spleen and pancreatic tail (Fig. 1); thus, distal pancreatectomy and splenectomy were performed. Multiple hepatic nodules were also excised (Fig. 2).

Multiseptated cystic lesion abutting the spleen and distal aspect of the pancreas.
Figure 1

Multiseptated cystic lesion abutting the spleen and distal aspect of the pancreas.

Resected spleen with multinodular cystic mass at the splenic hilum.
Figure 2

Resected spleen with multinodular cystic mass at the splenic hilum.

Histopathology

Microscopy revealed a poorly differentiated neoplasm with acinar differentiation arising from the pancreas. Metastases involved the omentum, transverse mesocolon, and right diaphragmatic surface. Immunohistochemistry confirmed acinar cell carcinoma.

Postoperative course

The patient recovered without complications and was discharged on postoperative Day 3with appropriate vaccinations and scheduled oncologic follow-up.

Discussion

PACC is a rare pancreatic malignancy, representing a small fraction of exocrine tumours and typically affecting older males [6]. Tumours are often large at diagnosis, with liver metastases occurring in approximately one-third of patients and elevated serum lipase in up to half [7]. Five-year survival ranges between 19% and 22% [7].

Unlike pancreatic ductal adenocarcinoma, PACC frequently presents with vague or absent symptoms, leading to incidental detection. The cystic appearance noted in our case is particularly rare; most PACCs are solid masses in the pancreatic head [1, 3]. Metastatic disease is common at presentation (up to 71%), with the liver, peritoneum, and lymph nodes being frequent sites [8].

The absence of symptoms in our patient, despite extensive metastatic spread, reflects the heterogeneity of PACC. Previous reports describe variability ranging from jaundice and markedly elevated tumour markers to completely normal laboratory studies [9, 10].

Molecular profiling differentiates PACC from ductal adenocarcinoma. While KRAS, TP53, and CDKN2A mutations are uncommon in PACC, BRCA1/2 and ATM alterations are more frequent, suggesting potential benefit from platinum agents and PARP inhibitors [9].

Surgical resection remains the cornerstone of management offering the best chance for a prolonged survival [11]. Chemotherapy, particularly multi-agent regimens such as FOLFIRINOX, has shown benefit in metastatic or node-positive disease [11, 12].

PACC generally carries a better prognosis than ductal adenocarcinoma; resected cases show 5-year survival rates between 36% and 72% [11, 13]. Multimodal approaches combining surgery and chemoradiation may further improve outcomes [7].

Our case demonstrates the need for early surgical intervention when imaging suggests malignancy, even in the absence of definitive preoperative tissue diagnosis. Limitations include lack of preoperative biopsy and unavailability of long-term follow-up data.

This case highlights several important clinical lessons, including that PACC should be considered even in young, asymptomatic women presenting with cystic pancreatic lesions, that early surgical intervention may be warranted in the presence of interval growth and radiologic suspicion for malignancy, and that close collaboration between radiology, surgery, oncology, and pathology teams is essential to optimize outcomes in such rare entities.

Conclusion

Pancreatic acinar cell carcinoma is a rare malignancy that may present with atypical demographics and cystic imaging features, leading to diagnostic uncertainty [14]. This case highlights the need to consider PACC even in young, asymptomatic patients with suspicious or enlarging cystic pancreatic lesions. Early surgical intervention [15] and a multidisciplinary approach are essential to achieve timely diagnosis and optimize outcomes in this uncommon entity [16].

Author contributions

R.H. wrote the Introduction. L.G. wrote the case presentation. D.E.H. and A.H. wrote the discussion. M.K.C. wrote the abstract and the conclusion. G.N. revised and edited the manuscript. All authors approved the final manuscript.

Conflicts of interest

The authors declare no conflicts of interest.

Funding

No funding was received for this study.

Data availability

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Ethics approval and informed consent

This study was approved by the ethics committee of mount-Lebanon hospital. Written informed consent was obtained from the patient.

References

1.

Ikezawa K, Urabe M, Kai Y  et al. Comprehensive review of pancreatic acinar cell carcinoma: epidemiology, diagnosis, molecular features and treatment. Jpn J Clin Oncol 2024;54:271–81.

2.

Shaib
 
WL
,
Zakka
 
K
,
Huang
 
W
 et al.  
Survival outcomes of acinar cell pancreatic cancer: a National Cancer Database Analysis
.
Pancreas.
 
2021
;
50
:
529
36
.

3.

Hu
 
F
,
Hu
 
Y
,
Wang
 
D
 et al.  
Cystic neoplasms of the pancreas: differential diagnosis and radiology correlation
.
Front Oncol
 
2022
;
12
:860740.

4.

Thompson
 
ED
,
Wood
 
LD
.
Pancreatic neoplasms with acinar differentiation: a review of pathologic and molecular features
.
Arch Pathol Lab Med
 
2020
;
144
:
808
15
.

5.

Zhou W, Han X, Fang Y  et al. Clinical analysis of acinar cell carcinoma of the pancreas: a single-center experience of 45 consecutive cases. Cancer Control 2020;

27
:1073274820969447.

6.

Ikezawa
 
K
,
Urabe
 
M
,
Kai
 
Y
 et al.  
Comprehensive review of pancreatic acinar cell carcinoma: epidemiology, diagnosis, molecular features and treatment
.
Jpn J Clin Oncol
 
2024
;
54
:
271
81
.

7.

Yasinzai
 
AQK
,
Iqbal
 
A
,
Olavarria-Bernal
 
D
 et al.  
Pancreatic acinar cell carcinoma: demographics, treatment, and survival outcomes, a retrospective population-based study
.
J Gastrointest Cancer
 
2025
;
56
:
106
9
.

8.

Cheng
 
M
,
Consul
 
N
,
Chung
 
R
 et al.  
Acinar cell carcinoma of the pancreas: can CT and MR features predict survival?
 
Cancer Imaging
 
2025
;
25
:
38
.

9.

Blair
 
AB
,
Radomski
 
SN
,
Chou
 
J
 et al.  
Survival outcomes and genetic characteristics of resected pancreatic acinar cell carcinoma
.
Ann Surg Oncol
 
2025
;
32
:
1869
78
.

10.

Xing-mao
 
Z
,
Hong-juan
 
Z
,
Qing
 
L
 et al.  
Pancreatic acinar cell carcinoma—case report and literature review
.
BMC Cancer
 
2018
;
18
:
1083
.

11.

Woo
 
KP
,
Wehrle
 
CJ
,
Remulla
 
D
 et al.  
The role of chemotherapy in the management of pancreatic acinar cell carcinoma
.
J Surg Oncol
 
2024
;
130
:
1624
33
.

12.

Yamada
 
S
,
Motegi
 
H
,
Kurihara
 
Y
 et al.  
A resected case of acinar cell carcinoma of the pancreas with liver metastasis following chemotherapy using modified FOLFIRINOX
.
Surg Case Rep
 
2023
;
9
:
147
1
.

13.

Zhao
 
F
,
Yang
 
D
,
Xu
 
T
 et al.  
New treatment insights into pancreatic acinar cell carcinoma: case report and literature review.
 
Front Oncol
 
2023
;
13
:1210064.

14.

Wang
 
J
,
Yang
 
J
,
Narang
 
A
 et al.  
Consensus, debate, and prospective on pancreatic cancer treatments
.
J Hematol Oncol
 
2024
;
17
:
92
.

15.

Hayat
 
U
,
Croce
 
PS
,
Saadeh
 
A
 et al.  
Current and emerging treatment options for pancreatic cancer: a comprehensive review
.
J Clin Med
 
2025
;
14
:
1129
.

16.

Conroy
 
T
,
Pfeiffer
 
P
,
Vilgrain
 
V
 et al.  
Pancreatic cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up
.
Ann Oncol
 
2023
;
34
:
987
1002
.

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com